CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ (55,118)	$ 46,047
Adjustments to net income (loss):
Depreciation and amortization	477,060	484,066
Deferred income tax expense (benefit)	10,776	16,407
Impairments and other charges	15,379	5,318
Amortization of debt discount and deferred financing costs	6,757	6,393
Losses (gains) on debt buyback	14,857	(25,202)
Losses (gains) on long-lived assets, net	17,109	7,980
Losses (gains) on investments, net	412	(1,089)
Share-based compensation	11,825	12,671
Foreign currency transaction losses (gains), net	21,317	21,725
Mark-to-market (gain) loss on warrants	(12,538)	(44,314)
Other	5,033	144
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(38,163)	(1,890)
Inventory	4,337	(18,305)
Other current assets	(6,900)	12,140
Other long-term assets	(1,311)	(786)
Trade accounts payable and accrued liabilities	583	(63,389)
Income taxes payable	(24,912)	(5,892)
Other long-term liabilities	(13,990)	3,917
Net cash provided by (used for) operating activities	432,513	455,941
Cash flows from investing activities:
Purchases of investments	(7,681)	(28,083)
Capital expenditures	(359,873)	(406,695)
Proceeds from sales of assets	9,667	9,677
Other	4,671	(3,873)
Net cash (used for) provided by investing activities	(353,216)	(428,974)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	550,000	250,000
Reduction in long-term debt	(1,197,024)	(296,547)
Debt issuance costs	(11,045)	(8,036)
Proceeds from revolving credit facilities	225,000	220,000
Reduction in revolving credit facilities	(225,000)	(220,000)
Payments for employee taxes on net settlement of equity awards	(2,634)	(7,079)
Dividends to common and preferred shareholders	(87)	(194)
Distributions to noncontrolling interest	(950)	(2,269)
Special purpose acquisition company redemptions by non-controlling redeemable shareholders		(186,933)
Sale of non-controlling interest - special purpose acquisition company		305,000
Other	(282)	274
Net cash (used for) provided by financing activities	(662,022)	54,216
Effect of exchange rate changes on cash and cash equivalents	(10,446)	(10,773)
Net increase (decrease) in cash and cash equivalents and restricted cash	(593,171)	70,410
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140
Cash and cash equivalents and restricted cash, end of period	781,011	807,550
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	1,057,487	451,025
Restricted cash, beginning of period	316,695	286,115
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140
Cash and cash equivalents, end of period	451,649	387,483
Restricted cash, end of period	$ 329,362	$ 420,067
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 781,011	$ 807,550